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Introduction
•
•

•

•

My future father-in-law was
diagnosed with celiac disease
(CD) approximately 2 years ago.
He was 60 years old at the time of
diagnosis and suffered with
diarrhea and abdominal pain for a
year prior to being told he had CD.
My fiancé and daughter are at
increased risk of developing CD
due to the genetic/hereditary
component of the disease.
Those who have a first-degree
relative with CD have a 4% to 17%
increased risk of developing the
disease compared to the general
population (Cui, Basen, Philipp,
Yusin, & Krishnaswamy, 2017).

About CD
•

•

•

•

CD was fist described by Samuel
Gee in 1887 and it wasn’t until
1941 that wheat was hypothesized
as the possible offending agent,
noted by William Dicke (Leonard,
Sapone, Catassi, & Fasano, 2017
).
CD was once thought to almost
exclusively affect young
Caucasian children, but can
actually occur at any age and can
affect almost any race (Leonard et
al., 2017).
The prevalence of CD is
estimated to be 0.6% to 1%
worldwide with approximately
0.7% to 0.8% of the United States
(US) population being affected
(Cui et al., 2017).
Non-Hispanic whites have an
approximately 4-8 times greater
prevalence of CD compared to
other races (Mardini, Westgate, &
Grigorian, 2015 ).

•
•
•

The classic presentation of CD manifests as gastrointestinal (GI) symptoms of diarrhea,
abdominal pain/distension and malnutrition, resulting in poor growth/failure to thrive in children
(Robinson, Davis, Vess, & Lebel, 2015).
However, the clinical presentation of CD varies from patient to patient with ailments presenting
as both intestinal and extra-intestinal symptoms (Green, Lebwohl, & Greywoode, 2015).
Intestinal symptoms include:
•
diarrhea, bloating, constipation, abdominal pain or weight loss (Leonard et al.,
2017).
Extra-intestinal symptoms include:
•
iron-deficiency anemia, dermatitis herpetifromis, vitamin deficiencies,
neurological or psychiatric problems and infertility (Lebwohl, Ludvigsson & Green,
2015).

Underlying Pathophysiology
•
•
•
•
•
•
•
•
•
•
•
•
•

•

The inflammatory process
described results in small
histologic abnormalities including:
•
“atrophy of the
intestinal villi,
hypertrophy of the
crypts and
lymphocytic
infiltration of
intraepithelial spaces
and lamina
propria”(Adelman, et
al., 2018).
Intestinal villi, pictured below, are
finger-like projections that line the
intestinal walls, allowing
absorption and digestion of
nutrients. (Celiac Disease
Foundation [CDF], 2017).
Undiagnosed CD, results in the
continued ingestion of gluten,
which results in continuous
inflammation that erodes and
flattens the villi, causing inefficient
uptake of nutrients as they pass
through the intestines (CDF,
2017).

•

CD is an autoimmune disorder occurring in genetically predisposed individuals.
Individuals who are genetically predisposed to CD have the HLA-DQ2 or HLA-DQ8
haplotype (Lebwohl et al., 2015).
While 30-40% of the general population are carriers for at least one of these alleles, the
absence of either allele has a “negative predictive value of 100% in excluding the diagnosis of
CD” (Green et al., 2015).
The pathogenesis of CD is dependent not only on being genetically predisposed to the
disease , but is also dependent on exposure to gluten and other environmental factors (Green
et al., 2015).
Gluten is the storage protein present in wheat, rye and barely (Cui et al., 2017).
It is a mixture of gliadin and glutenin’s, complex proteins that are not completely digested by
intestinal enzymes. This triggers an inflammatory process, as these proteins are mistaken as
pathogens (Leonard et al., 2017).
Partially digested gliadins then enter through the epithelial barrier of the small intestinal
mucosa, triggering innate and adaptive immune responses (Lebwohl et al., 2015).
Once through the epithelial barrier, gliadins are “deamidated by the enzyme transglutaminase
(TTG)” (Green et al., 2015).
This process increases the immunogenicity of gliadin, by altering the charge that facilitates
binding to the HLA-DQ2 or HLA-DQ8 molecule on antigen presenting cells (Lebwohl et al.,
2015).
Gliadin CD4 positive T cells recognize gliadin peptides and in turn produce proinflammatory
cytokines (Lebwohl et al., 2015).
During the inflammatory cascade, the release of metalloproteinases and other tissue
damaging mediators cause tissue injury, leading to epithelial lesions which cause the
symptoms seen in the clinical manifestations of CD (Lebwohl et al., 2015).
Other environmental factors have been attributed to the pathogenesis of CD, including
infections of the GI tract and alterations in the intestinal microbiota (Green et al., 2015).
Examples of intestinal alterations include bacteria such as the Bacteroides species, which are
thought to play a pathogenic role in the development and manifestation of symptoms in CD
(Green et al., 2015).

•

Diagnosis of CD includes serologic
and genetic testing, as well as
duodenal biopsy if positive results
are found in the initial tests (Cui et
al., 2017).
Duodenal biopsy is performed via
upper endoscopy where 2 samples
are obtained from the duodenal bulb
and at least 4 from the rest of the
duodenum (Cui et al., 2017).
Samples are then examined, mainly
assessing the extent of villous
atrophy.
The extent of atrophy is classified
based on the Marsh scale, a seven
level classification system, with a 0
indicating normal intestinal villi, and
a 4 indicating flat, fully atrophied
intestinal villi (CDF, 2017).
The picture below depicts the Marsh
Scale Classification in the
assessment of villous atrophy.
The gold standard for diagnosis of
CD is villous atrophy on biopsy and
return of normal villi after adherence
to a gluten free diet (Cui et al.,
2017).

•

•
•

•
•

•
•

•

•

•

•

CD is increasing in prevalence, although it is
generally underdiagnosed (Green et al., 2015 ).
Therefore, it is important for healthcare providers to
recognize not only the GI symptoms present in CD
but to also assess the cause of any extra-intestinal
findings as well.
•
Patient’s with otherwise unexplained
iron-deficiency anemia, as well as
those who do not respond to oral iron
therapy, should be tested for celiac
disease (Leonard et al., 2017).
CD commonly leads to nutritional deficiencies such
as:
•
iron, folic acid, vitamin B12 and B6,
copper, zinc and vitamin D deficiencies
(Cui et al., 2017).
Delayed diagnosis of CD showed more severe
villous atrophy at diagnosis, which predicted slower
mucosal healing in the one year follow-up biopsy, as
detailed in a study performed by Pekki et al. (2015).
Increasing provider awareness about celiac disease
could improve healthcare-associated costs by
preventing repetitive testing and misdiagnosis
(Robinson et al., 2015).
Patient education is key in the success of treatment
for CD, as strict adherence to a gluten free (GF) diet
is the main therapeutic intervention for this disease
process (Green et al., 2015).
Resources should be given to patient’s on how to
contact a dietician upon diagnosis, as low adherence
to a GF diet, predisposes patient’s to incomplete
mucosal recovery, which leads to decreased quality
of life due to incomplete resolution of intestinal and
extra-intestinal symptoms (Pekki et al., 2015).

Conclusion
•

Diagnostic Testing
•

•
(Lebwohl et al., 2015)

•

•

•

(The University of Chicago Celiac
Disease Center, n.d.)

Implications for Nursing

Significance of Pathophysiology

Signs and Symptoms
•

In addition to duodenal biopsy,
serologic and genetic testing can be
performed for diagnosis of CD.
Serologic testing measures the levels
of:
•
anti-tissue
transglutaminase (tTG)
•
Anti-endomysium
(EMA)
•
Anti-deamidated gliadin
peptides (DGP) (Green
et al., 2015).
First line testing to screen for CD
includes measurement of serum IgA
antibodies to tTG (Leonard et al.,
2017).

•

•

•

(Adelman et al., 2018)

This test has a high sensitivity and
specificity and is the first test that
should be ordered when CD is
suspected (Leonard et al., 2017).
If serum IgA levels are < 0.2%, or
the patient is younger than 2 years
of age, then the test of choice is
measurement of IgG levels to
DGP (Cui et al., 2017).
Genetic testing can be considered
for patient’s whose serologic and
histologic results are inconsistent
(Cui et al., 2017).

•

•

•

•

The reason for an increasing prevalence of CD is
still unknown, as is the extent to which
environmental factors other than gluten contribute
to the development of CD (Green et al., 2015)
The development of CD occurs among subjects
with HLA-DQ2 or HLA-DQ8 genes who are
exposed to gluten and other environmental factors
(Green et al., 2015).
Diagnosis of CD is based on characteristic
autoantibodies seen in serologic testing, as well as
with small intestinal histological changes upon
examination of biopsy sample (Green et al., 2015).
Early diagnosis can prevent the extent of villous
atrophy seen, which positively correlates to the
rate of mucosal healing and resolution of
symptoms seen in CD (Pekki et al., 2015).
Adherence to a strict GF diet is the best predictor
of remission of the disease.
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